- Czaja, A.J. (1996) "The variant forms of autoimmune hepatitis". Ann. Intern. Med. 125, 588-598.
- Czaja, A. J. (1998) "Frequency and nature of the variant syndromes of autoimmune liver disease". Hepatology 28, 360-365.
- Czaja, A. J. (1991) "Variant forms of autoimmune hepatitis", Curr. Gastroenterol. Rep. 1, 63-70.
- Ben-Ari, Z. and Czaja, A.J. (2001) "Autoimmune hepatitis and its variant syndromes", Gut 49, 589-594.
- Woodward, J. and Neuberger, J. (2001) "Autoimmune overlap syndromes", Hepatology 33, 994-1002.
- Czaja, A.J., Carpenter, H.A., Santrach, P.J., Moore, S.B. and Homburger, H.A. (1993) "The nature and prognosis of severe cryptogenic chronic active hepatitis", Gastroenterology 104, 1755-1761.
- Kenny, R.P., Czaja, A.J., Ludwig, J. and Dickson, E.R. (1986) "Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis". Dig. Dis. Sci. 31, 705-711.
- Duclos-Vallee, J-C., Hadengue, A., Ganne-Carrie, N., Robin, E., Degott, C. and Erlinger, S. (1995) "Primary biliary cirrhosisautoimmune hepatitis overlap syndrome: corticoresistance and effective treatment with cyclosporine A", Dig. Dis. Sci. 40, 1069-1073.
- Chazouilleres, O., Wendum, D., Serfaty, L., Montebault, S., Rosmorduc, O. and Poupon, R. (1998) "Primary biliary cirrhosisautoimmune hepatitis overlap syndrome: clinical features and response to therapy", Hepatology 28, 296-301.
- Lohse, A.W., Meyer zum Buschenfelde, K.H., Kanzler, F.B., Gerken, G. and Dienes, H. P (1999) "Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals", Hepatology 29, 1078-1084.
- Perdigoto, R., Carpenter, H.A. and Czaja, A.J. (1992) "Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis", J. Hepatol. 14, 325-331.
- Rabinovitz, M., Demetris, A.J., Bou-Abboud, C.F. and Van Thiel, D.H. (1992) "Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis", Din. Dis. Sci. 37, 1606-1611.
- Boberg, K.M., Fausa, O., Haaland, T., Holter, E., Mellbye, O.J., Spurkland, A., et al. (1996) "Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis", Hepatology 23, 1369-1376.
- Gohlke, F., Lohse, A.W., Dienes, H.P. Lohr, H., Marker-Hermann, E., Gerken, G., et al. (1996) "Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis", J. Hepatol. 24, 699-705.
- Luketic, V.A.C., Gomez, D.A., Sanyal, A.J. and Shiffman, M.L. (1997) "An atypical presentation for primary sclerosing cholangitis", Dig. Dis. Sci. 42, 2009-2016.
- McNair, A.N.B., Moloney, M., Portmann, B.C., Williams, R. and McFarlane, I.G. (1998) "Autoimmune hepatitis overlapping with primary sclerosing cholangitis in S cases", Am. J. Gastroenterol. 93, 777-784.
- Ben-Ari, Z., Dhillon, A.P. and Sherlock, S. (1993) "Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis", Hepatology 18, 10-15.
- Colombato, L.A., Alvarez, F., Cote, J. and Huet, P.M. (1994) "Autoimmune cholangiopathy: the result of primary biliary cirrhosis and autoimmune hepatitis", Gastroenterology 107, 1839-1843.
- Michieletti, P. Wanless, I.R., Katz, A., Scheuer, P.J., Yeaman, S.J., Bassendine, M.F., er dl. (1994) "Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis". Gut 35, 260-265.
- Taylor, S.L., Dean, P.J. and Riely, C.A. (1994) "Primary autoimmune cholangitis: an alternative to antimitochondrial antibody-negative primary biliary cirrhosis", Am. J. Clin, Pathol. 18, 91-99.
- Goodman, Z.D., McNally, P.R., Davis, D.R. and Ishak, K.G. (1995) "Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases", Dig. Dis. Sci. 40, 1232-1242.
- Sherlock, S. (1998) "Autoimmune cholangitis: a unique entity?". Mayo Clin. Proc. 73, 184-190.
- Czaja, A.J., Carpenter, H.A., Santrach, P.J. and Moore, S.B. (2000) "Autoimmune cholangitis within the spectrum of autoimmune liver disease", Hepatology 31, 1231-1238.
- Czaja, A.J. (1993) "Chronic active hepatitis: the challenge for a new nomenclature". Ann. Intern. Med. 119, 510-517.
- Heathcote, J. (2002) "Variant syndromes of autoimmune hepatitis", Clin. Liver. Dis. 6, 381-396.
- Czaja, A.J. and Carpenter, H.A. (2001) "Autoimmune hepatitis with incidental histologic features of bile duct injury", Hepatology 34, 659-665.
- Czaja, A.J., Santrach, P.J. and Moore, S.B. (2001) "Shared genetic risk factors in autoimmune liver disease", Dig. Dis. Sci. 46, 140-147.
- Carpenter, H.A. and Czaja, A.J. (2002) "The role of histological evaluation in the diagnosis and management of autoimmune hepatitis and its variants". Clin. Liver Dis. 6, 397-417.
- Baeres, M., Herkel, J., Czaja, A.J., Wies, I., Kanzler, S., Cancado, E.L.R., et al. (2002) "Establishment of standardized SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence and clinical characteristics". Gut 51, 259-264.
- Czaja, A.J., Donaldson, P.T. and Lohse, A.W. (2002) "Antibodies to soluble liver antigen/liver pancreas and HLA risk factors in type 1 autoimmune hepatitis", Am. J. Gastroenterol. 97, 413-419.
- Alvarez, F., Berg, P.A., Bianchi, F.B., Bianchi, L., Burroughs, A.K., Cancado, E.L., et al. (1999) "International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis". J. Hepatol. 31, 929-938.
- Czaja, A.J. and Freese, D.K. (2002) "Diagnosis and treatment of autoimmune hepatitis", Hepatology 36, 479-497.
- Czaja, A.J., Strettell, M.D.J., Thomson, L.J., Santrach, P.J., Moore, S.B., Donaldson, P.T. et al. (1997) "Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis". Hepatology 25, 317-323.
- Czaja, A.J., Cassani, F., Cataleta, M., Valentini, P. and Bianchi, F.B. (1996) "Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis", Hepatology 24, 1068-1073.
- Czaja, A.J., Carpenter, H.A. and Manns, M.P. (1993) "Antibodies to soluble liver antigen. P450IID6. and mitochondrial complexes in chronic hepatitis", Gastroenterology 105, 1522-1528.
- Czaja, A.J., Nishioka, M., Morshed, S.A. and Hachiya, T. (1994) "Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis", Gastroenterology 107, 200-207.
- Czaja, A.J., Cassani, F., Cataleta, M., Valentini, P. and Bianchi, F.B.(1997) "Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis", Dig. Dis. Sci. 42, 1688-1696.
- Homburger, H.A., Cahen, Y.D., Griffiths, J. and Jacob, G.L. (1998) "Detection of antinuclear antibodies. Comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods", Arch. Pathol. Lab. Med. 122, 993-999.
- Czaja, A.J. and Homburger, H.A. (2001) "Autoantibodies in liver disease", Gastroenterology 120, 239-249.
- Czaja, A.J., Manns, H.P. and Homburger, H.A. (1992) "Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis", Gastroenterology 103, 1290-1295.
- Czaja, A.J. (1999) "Drug therapy in the management of type 1 autoimmune hepatitis", Drugs 57, 49-68.
- Summerskill, W.H.J., Korman, M.G., Ammon, H.V. and Baggenstoss, A.H. (1975) "Prednisone for chronic active liver disease: dose titration. standard dose, and combination with azathioprine compared", Gut 16, 876-883.
- Czaja, A.J., Wolf, A.M. and Baggenstoss, A.H. (1981) "Laboratory assessment of severe chronic active liver disease (CALD): correlation of serum transaminase and gamma globulin levels with histologic features", Gastroenterology 80, 687-692.
- Czaja, A.J., Menon, K.V.N. and Carpenter, H.A. (2002) "Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis", Hepatology 35, 890-897.
- Czaja, A.J. and Carpenter, H.A. (1993) "Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis", Gastroenterology 105, 1824-1832.
- Wies, I., Brunner, S., Henninger, J., Herkel, J., Meyer zum Buschenfelde, K.H. and Lohse, A.W. (2000) "Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis", Lancet 355, 1510-1515.
- Kanzler, S., Weidemann, C., Gerken, G., Lohr, H.F., Galle, P.R., Meyer zum Buschenfelde, K.H., et al. (1999) "Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis". J. Hepatol. 31, 635-640.
- Kernebeck, T., Lohse, A.W. and Grotzinger, J. (2001) "A bioinformatical approach suggests the function of the autoimmune hepatitis target soluble liver antigen/liver pancreas". Hepatology 34, 230-233.
- Gelpi, C., Sontheimer, E.J. and Rodriguez-Sanchez, J.L. (1992) "Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion". Proc. Natl. Acad. Sci. USA 89, 9739-9743.
- Costa, M., Rodriques-Sanchez, J.L., Czaja, A.J. and Gelpi, C. (2000) "Isolation and characterization of cDNA encoding the antigenic protein of the human tRNA(Ser)Sec complex recognized by autoantibodies from patients with type 1 autoimmune hepatitis", Clin. Exp. Immunol. 121, 364-374.
- Volkmann, M., Martin, L., Baurle, A., Heid, H., Strassburg, C.P. Trautwein. C., et al. (2001) "Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically reacts with sera from patients with autoimmune hepatitis", Hepatalogy 33, 591-596.
- Czaja, A.J. (1999) "Behavior and significance of autoantibodies in type 1 autoimmune hepatitis", J. Hepatol. 30, 394-401.
- Czaja, A.J. and Carpenter, H.A. (1996) "Validation of a scoring system for the diagnosis of autoimmune hepatitis". Dig. Dis. Sci. 41, 305-314.
- Ma, Y., Okamoto, M., Thomas, M.G., Bogdanos, D.P. Lopes, A.R., Portmann, B., et al. (2002) "Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease", Hepatology 35, 658-664.
- McFarlane, I.G., Hegarty, J.E., McSorley, C.G., McFarlane, B.M. and Williams, R. (1984) "Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis", Lancet 2, 954-956.
- Czaja, A.J., Pfeifer, K.D., Decker, R.H. and Vallari, A.S. (1996) "Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis", Dig. Dis. Sci. 41, 1733-1740.
- Czaja, A.J. (2001) "Understanding the pathogenesis of autoimmune hepatitis", Am. J. Gastroenterol. 96, 1224-1231.
Frequency and Significance of Antibodies to Soluble Liver Antigen/Liver Pancreas in Variant Autoimmune Hepatitis
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.